Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.96
1.31 (28.17%)
At close: Aug 15, 2025, 3:59 PM
5.60
-6.01%
After-hours: Aug 15, 2025, 07:58 PM EDT
Karyopharm Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 37.93M | 30.02M | 30.54M | 38.78M | 42.79M | 33.13M | 33.75M | 36.01M | 37.58M | 38.7M | 33.58M | 36.15M | 39.68M | 47.67M | 126.27M | 37.69M | 22.6M | 23.26M |
Cost of Revenue | 1.05M | 1.3M | 1.33M | 1.3M | 1.56M | 2M | 1.56M | 911K | 1.19M | 1.35M | 1.87M | 980K | 939K | 1.43M | 742K | 589K | 1.14M | 933K |
Gross Profit | 36.88M | 28.71M | 29.21M | 37.48M | 41.23M | 31.13M | 32.18M | 35.1M | 36.38M | 37.35M | 31.71M | 35.16M | 38.74M | 46.24M | 125.53M | 37.1M | 21.46M | 22.33M |
Operating Income | -24.39M | -33.26M | -31.28M | -26.28M | -28.12M | -33.76M | -37.81M | -31.26M | -29.57M | -30.9M | -33.87M | -30.84M | -42.91M | -34.59M | 46.96M | -43.81M | -49.05M | -52.37M |
Interest Income | 613K | 1M | 1.48M | 1.83M | 1.93M | 2.16M | 2.52M | 2.75M | 2.82M | 2.85M | 1.33M | 658K | 293K | 74K | 55K | 98K | 165K | 264K |
Pretax Income | -37.21M | -23.43M | -30.89M | -32.04M | 23.86M | -37.29M | -41.71M | -34.49M | -32.5M | -34.07M | -38.43M | -36.28M | -48.94M | -41.27M | 38.6M | -51.71M | -53.45M | -57.27M |
Net Income | -37.25M | -23.46M | -30.78M | -32.07M | 23.79M | -37.36M | -41.84M | -34.51M | -32.63M | -34.13M | -38.51M | -36.32M | -49.06M | -41.4M | 38.72M | -51.81M | -53.58M | -57.41M |
Selling & General & Admin | 28.48M | 27.35M | 27.19M | 27.63M | 31.07M | 29.55M | 30.69M | 30.8M | 34.48M | 35.91M | 34.65M | 34.65M | 37.34M | 38.77M | 34.56M | 35.1M | 36.53M | 37.65M |
Research & Development | 32.79M | 34.62M | 33.3M | 36.13M | 38.28M | 35.34M | 39.3M | 35.55M | 31.48M | 32.34M | 30.93M | 31.36M | 44.31M | 42.06M | 44M | 45.81M | 33.98M | 37.05M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | n/a | -13K | 16K | -13K | -73K | -478K | 18K | 436K | -61K |
Operating Expenses | 61.27M | 61.97M | 60.49M | 63.77M | 69.35M | 64.89M | 69.99M | 66.36M | 65.96M | 68.25M | 65.58M | 66M | 81.65M | 80.83M | 78.56M | 80.91M | 70.51M | 74.7M |
Interest Expense | 11.23M | 10.99M | 11.2M | 11.38M | 8.95M | 5.88M | 6.21M | 6.07M | 5.78M | 5.76M | 5.88M | 6.11M | 6.31M | 6.68M | 7.94M | 8.01M | 5M | 5.09M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 62.32M | 63.27M | 61.82M | 65.07M | 70.91M | 66.89M | 71.56M | 67.27M | 67.15M | 69.6M | 67.45M | 66.98M | 82.59M | 82.26M | 79.31M | 81.5M | 71.65M | 75.63M |
Income Tax Expense | 40K | -36K | -109K | 28K | 67K | 71K | 130K | 12K | 127K | 54K | 73K | 45K | 121K | 130K | -121K | 106K | 134K | 149K |
Shares Outstanding (Basic) | 8.62M | 8.47M | 8.39M | 8.33M | 8.07M | 7.7M | 7.65M | 7.63M | 7.61M | 7.57M | 6M | 5.35M | 5.31M | 5.17M | 5.04M | 5.03M | 5.01M | 4.97M |
Shares Outstanding (Diluted) | 8.62M | 8.47M | 8.39M | 8.33M | 10.29M | 7.7M | 7.65M | 7.63M | 7.61M | 7.57M | 6M | 5.35M | 5.31M | 5.17M | 5.79M | 5.03M | 5.01M | 4.97M |
EPS (Basic) | -4.32 | -2.77 | -3.67 | -3.85 | 2.25 | -4.85 | -5.47 | -4.52 | -4.29 | -4.51 | -6.42 | -6.79 | -9.24 | -8.01 | 7.68 | -10.3 | -10.69 | -11.56 |
EPS (Diluted) | -4.32 | -2.77 | -3.67 | -3.85 | -2.97 | -4.85 | -5.47 | -4.52 | -4.29 | -4.51 | -6.42 | -6.79 | -9.24 | -8.01 | 6.69 | -10.3 | -10.69 | -11.56 |
EBITDA | -24.39M | -12.35M | -19.6M | -20.58M | 32.9M | -31.32M | -35.42M | -28.34M | -26.64M | -28.02M | -32.44M | -29.98M | -42.48M | -34.41M | 46.68M | -43.51M | -48.22M | -51.94M |
EBIT | -25.98M | -12.43M | -19.68M | -20.66M | 32.81M | -31.41M | -35.5M | -28.42M | -26.72M | -28.31M | -32.55M | -30.16M | -42.63M | -34.59M | 46.54M | -43.7M | -48.45M | -52.17M |
Depreciation & Amortization | 78K | 78K | 81K | 83K | 91K | 85K | 77K | 80K | 83K | 290K | 113K | 182K | 149K | 177K | 139K | 186K | 229K | 235K |